Sargent Investment Group LLC Trims Position in The Procter & Gamble Company (NYSE:PG)

Sargent Investment Group LLC lessened its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 1.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,558 shares of the company’s stock after selling 234 shares during the period. Sargent Investment Group LLC’s holdings in Procter & Gamble were worth $2,573,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Dfpg Investments LLC increased its position in Procter & Gamble by 1.7% during the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after purchasing an additional 424 shares during the period. Garrett Wealth Advisory Group LLC boosted its holdings in shares of Procter & Gamble by 6.3% in the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company’s stock valued at $645,000 after buying an additional 260 shares in the last quarter. Herold Advisors Inc. boosted its holdings in shares of Procter & Gamble by 2.2% in the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after buying an additional 581 shares in the last quarter. N.E.W. Advisory Services LLC boosted its holdings in shares of Procter & Gamble by 14.6% in the 3rd quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company’s stock valued at $13,772,000 after buying an additional 12,016 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Procter & Gamble by 0.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock valued at $2,298,184,000 after buying an additional 131,339 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded down $1.26 during trading on Friday, hitting $161.29. 5,659,784 shares of the stock traded hands, compared to its average volume of 6,820,118. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The company has a market cap of $380.67 billion, a price-to-earnings ratio of 26.35, a P/E/G ratio of 3.27 and a beta of 0.44. The company has a fifty day moving average price of $159.64 and a two-hundred day moving average price of $153.57. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $164.32.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business’s quarterly revenue was up .6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.37 EPS. As a group, equities analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Procter & Gamble news, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at $5,943,835.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now owns 11,507 shares in the company, valued at $1,858,265.43. The disclosure for this sale can be found here. Insiders have sold 100,865 shares of company stock valued at $16,029,280 over the last 90 days. 0.17% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have recently weighed in on PG shares. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price target on the stock. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their target price for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Argus lifted their target price on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Raymond James lifted their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $169.76.

Check Out Our Latest Stock Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.